Transarterial Chemoembolization Complicated by Deteriorating Hepatic Function
نویسندگان
چکیده
منابع مشابه
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
BACKGROUND/AIMS Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there is some evidence for the benefits of preemptive antiviral therapy in TACE. This study evaluated the effect of preemptive antiviral therapy on acute hepati...
متن کاملFatal liver abscess caused by Clostridium perfringens complicated with transarterial chemoembolization
A 77-year-old man who received transarterial chemoembolization for large hepatocellular carcinomas complained of acute pain in the upper abdomen and suddenly developed severe jaundice, anemia, and massive hematuria. Abdominal computed tomography demonstrated gas gangrene at the tumor site. Clostridium perfringens was identified from blood samples and drainage cultures from the liver abscess. De...
متن کاملTransarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is common cancer in the world. Hepatitis B/C or alcoholic cirrhosis is usually underlying condition. Surgical resection is curative treatment for small HCC, however most patients usually present when advanced or inoperable disease. Transarterial chemoembolization (TACE) is most common alternative treatment for early and advanced HCC. Curative treatment is possible...
متن کاملTransarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
PURPOSE In hepatocellular carcinoma patients with large or multinodal tumors, where curative treatment options are not feasible, transarterial therapies play a major role. Transarterial chemoembolization (TACE) with drug-eluting beads (DEB-TACE) is a promising new approach due to higher intratumoral and lower systemic concentration of the chemotherapeutic agent compared to conventional TACE (cT...
متن کاملLocoregional Transarterial Therapies for Hepatocellular Carcinoma: Transarterial Chemoembolization and Radioembolization
Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third most common cause of cancer-related mortality. Despite the widespread implementation of surveillance programs, more than half of the patients with HCC are diagnosed at late stages, when curative treatments (resection or liver transplantation) cannot be applied. For patients presenting with unre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Interventional Radiology
سال: 2011
ISSN: 0739-9529,1098-8963
DOI: 10.1055/s-0031-1280664